CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 85.27%
This Quarter Est. Return
1 Year Est. Return
+85.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.32B
AUM Growth
-$500M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1 +$15.6M
2 +$15.3M
3 +$13.8M
4
BBIO icon
BridgeBio Pharma
BBIO
+$13.8M
5
MTSR
Metsera Inc
MTSR
+$10.9M

Top Sells

1 +$19.2M
2 +$16.4M
3 +$15.6M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$13.4M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$13.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLTX icon
1
MoonLake Immunotherapeutics
MLTX
$596M
$332M 24.95%
8,494,151
EWTX icon
2
Edgewise Therapeutics
EWTX
$1.61B
$90.2M 6.79%
4,101,992
+695,458
BBIO icon
3
BridgeBio Pharma
BBIO
$10.5B
$69.1M 5.2%
2,000,000
+400,000
ACLX icon
4
Arcellx
ACLX
$4.93B
$68.9M 5.18%
1,050,000
-250,000
PRAX icon
5
Praxis Precision Medicines
PRAX
$3.42B
$66.1M 4.97%
1,745,000
+51,781
NAMS icon
6
NewAmsterdam Pharma
NAMS
$4.11B
$57.8M 4.35%
2,825,000
-425,000
JANX icon
7
Janux Therapeutics
JANX
$1.63B
$54M 4.06%
2,000,000
-100,000
EYPT icon
8
EyePoint Pharmaceuticals
EYPT
$796M
$45.1M 3.39%
8,325,000
INSM icon
9
Insmed
INSM
$34.5B
$40.1M 3.01%
525,000
-125,000
DRUG
10
Bright Minds Biosciences
DRUG
$471M
$38.2M 2.87%
1,059,331
BBOT
11
BridgeBio Oncology
BBOT
$903M
$32.9M 2.47%
2,909,000
CNTA
12
Centessa Pharmaceuticals
CNTA
$3.06B
$32.5M 2.45%
2,261,600
-300,000
MRUS icon
13
Merus
MRUS
$7.19B
$31.1M 2.34%
740,000
RAPP
14
Rapport Therapeutics
RAPP
$1.15B
$29.5M 2.22%
2,940,921
AXSM icon
15
Axsome Therapeutics
AXSM
$6.24B
$29.2M 2.19%
250,000
-75,000
PHVS icon
16
Pharvaris
PHVS
$1.41B
$23M 1.73%
1,466,460
GHRS icon
17
GH Research
GHRS
$857M
$22.2M 1.67%
2,009,482
+1,416,439
ARQT icon
18
Arcutis Biotherapeutics
ARQT
$2.51B
$21.1M 1.59%
1,350,000
-475,000
TARS icon
19
Tarsus Pharmaceuticals
TARS
$3.16B
$20.5M 1.55%
400,000
-100,000
SPRY icon
20
ARS Pharmaceuticals
SPRY
$999M
$20.1M 1.51%
1,600,000
+1,100,000
CRNX icon
21
Crinetics Pharmaceuticals
CRNX
$3.98B
$20.1M 1.51%
600,000
-400,000
CGON icon
22
CG Oncology
CGON
$3.19B
$19M 1.43%
775,000
CRGX
23
DELISTED
CARGO Therapeutics
CRGX
$13.8M 1.03%
3,381,277
+2,198,714
ABVX
24
Abivax
ABVX
$7.23B
$13.3M 1%
2,130,000
ALMS
25
Alumis Inc
ALMS
$480M
$13.2M 0.99%
2,147,396